It’s been over 18 months since I last covered Lightwave Logic and the company still has no revenues despite a commercial agreement in May 2023. I’m pessimistic about the commercialization of the ...

Natick-based cancer detection firm Mercy BioAnalytics has added two executive positions to its roster ahead of commercialization plans for its product. The firm secured $41 million in May in its ...

Healy confirmed, "we continue to expect that we will deliver all 10 Early Adopter units in 2025. Based on our current development and build schedule, we now expect that additional KARNO unit ...

“Promoted Content” articles are written by our staff reporters. They are promoted to some extent by an external company. Promoted Content is not the same as “Guest Reports,” which are paid ...

BOSTON--(BUSINESS WIRE)--Micropep Technologies (Micropep), a global leader in micropeptide technology, today announced the appointment of Alexandre Frateschi as its new chief business officer. He is a ...

Stereotaxis, Inc. announced it has secured approximately $12.5 million through a registered direct stock offering priced at $2.00 per share, led by a strategic industry partner and select ...

Seres Therapeutics launched VOWST for recurrent C. difficile infection in early June, in partnership with Nestle Health. VOWST represents a significant improvement over current standard of care.

Having a strong company culture is a competitive advantage that drives the ability to attract top talent and foster innovation. In many biotechs' early stages, they cultivate a research-focused ...

In today's global marketplace, intellectual property (IP) rights are not merely legal tools but strategic assets that can significantly influence a product's lifecycle, from development to market.

Earnings Call Insights: NeuroOne Medical Technologies Corporation (NMTC) Q4 2025 Rosa explained the company will issue financial guidance for fiscal 2026 after receiving final projections from Zimmer ...